Today’s AI Top Pick: INSP
9/4/2026 · Quality Squeeze screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live INSP price forecast →
Inspire Medical is the cleanest multi-timeframe forecast alignment in the pool. Every available horizon points up and the magnitudes escalate as you go out: 4h fc_short +25.41% / fc_mid +52.27% / fc_long +84.09%; 1d fc_short +4.11% / fc_mid +15.69% / fc_long +48.28%; 1wk fc_short +15.61% / fc_mid +115.66% / fc_long +165.35%. bullish_prob 0.80 confirms the model conviction, and this is coming off a deeply beaten-down base (perfYear -27.41%, perfYtd -32.62%), so the forecast is calling a recovery leg, not chase-the-parabola. The fundamentals cleanly pass the quality-squeeze screen: ROE 17.96, profit margin 15.03, debt/equity 0.04 (near zero), short float 16.04, gross margin a huge 86.13%. Trailing PE 13.5 is reasonable for a med-device franchise; the ugly fwdPe 42.27 reflects near-term margin compression (operMargin only 6.02), which is exactly why the stock got crushed and why the setup is a bounce, not a momentum blow-off. Institutional ownership 124% (heavy short-covering fuel) sits directly under the 16% short float — that's the classic squeeze ammunition the screen is built to find. The honest pushback: pos_in_21bar_range 92-100% across every timeframe means we're at the top of the near-term range on entry — this is not a pullback buy, it's a breakout buy, and near_term_bullish is only 0.4. That's why the entry plan below scales in rather than YOLOs. Analyst targetUpsidePct of -2.8% is also a yellow flag — the tape/model disagree with sell-side, and I'm siding with the tape given the magnitude of the forecast. Why today vs. wait: the daily drawdown is only -0.95% and the weekly forecast just flipped to a massive +115/+165% mid/long profile — waiting for a pullback risks missing a base breakout on a name whose news flow is neutral-to-positive (Zacks 'add to portfolio', long-term healthcare pick). Names with stronger charts (PSIX, UPWK) have material news problems (guidance cut at UPWK, weekly forecast collapse at PSIX). INSP's setup + fundamentals + no landmine headlines wins by process of elimination.
- pos_in_21bar_range 92-100% across all TFs — buying at the top of the near-term range, no cushion if the breakout fails
- fwdPe 42.27 vs trailing PE 13.5 signals sharp forward earnings compression; operMargin only 6.02% shows the profitability squeeze is real
- Analyst targetUpsidePct is -2.8% and recom 2.78 — sell-side is not on board, so this trade is a bet against consensus
- near_term_bullish is only 0.4 despite bullish_prob 0.8 — short-horizon signals lag the longer forecasts, could chop before it runs
- Sleep-apnea device space faces GLP-1 headwinds narrative — any renewed weight-loss-drug efficacy print in OSA could re-crater the stock
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | INSP | BUY NOW | 8.4 | Every timeframe forecast points up with escalating magnitude (1wk fc_long +165%), bullish_prob 0.80, clean fundamentals — pay for the breakout. |
| 2 | TDC | BUY NOW | 7.6 | PE 6, ROE 119, near_term 0.8, bullish 0.8, fresh Microsoft AI catalyst and post-earnings drift — solid all-around setup. |
| 3 | LYFT | BUY NOW | 6.6 | Cheap (PE 2.42), 4h fc_long +18.46%, near_term 0.6, bullish 0.6 — quiet compounder setup. |
| 4 | CRMD | BUY PULLBACK | 6.2 | PE 4, ROE 54, profit margin 40, Zacks upgrade to Buy, but 1wk fc_long -18.53% undercuts the intermediate case. |
| 5 | PSIX | BUY PULLBACK | 6.0 | bullish_prob 1.0 and 4h/1d forecasts are explosive (+80-120%), but 1wk fc_long -54% is a serious warning to size small and wait. |
| 6 | UPWK | WAIT | 5.6 | Great forecast (4h fc_long +118%) and fwdPe 6.73, but the recent growth-outlook cut is a real thesis dent. |
| 7 | DUOL | WAIT | 5.2 | Evercore raised target to $210 and 1wk fc_long +14.38%, but 1d fc_short -13% at pos 99% is a textbook chase-and-fade risk. |
| 8 | LRN | WAIT | 4.6 | Cheap and top-of-pool fundamental_score 5.75, but 1wk fc_mid -15.16% and SeekingAlpha downgrade on enrollment weakness are a real drag. |
| 9 | DUOT | WAIT | 4.2 | bullish 1.0 and near basing lows (pos 5-12%), but 1wk fc_long -32% and negative operMargin -32% keep it a coin flip. |
| 10 | EVER | AVOID | 3.8 | 1d and 1wk fc_long both -23%+, CTO insider selling, peg 17.61 — forecast is deteriorating. |
| 11 | AUGO | AVOID | 3.6 | Fantastic fundamentals (ROE 100, PEG 0.14) but 4h/1d fc_long -24%/-23% and perfYear +184% says the gold move is exhausted. |
| 12 | DLO | AVOID | 3.4 | pos 100% on 1d and 1wk with fc_long -19%/-24% — classic top-of-range fade setup despite Truist buy. |
| 13 | SGHC | AVOID | 3.0 | Great fundamentals but pos 100% 1d and 1wk fc_long -57% — the tape is calling a top. |
| 14 | SEZL | AVOID | 2.6 | 4h dd -33% and every horizon forecast negative (1wk fc_long -37%), pre-market weakness confirms. |
| 15 | LQDA | AVOID | 1.8 | Positive FDA fast-track headline can't offset 1wk fc_long -83.53% and 1d dd -25% — model is screaming distribution. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord